-->

Tag: mirvetuximab soravtansine-gyn

Home / mirvetuximab soravtansine-gyn

Categories

Mirvetuximab soravtansine-gynx is granted accelerated approval for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal cancer

November 2022: For adult patients who have had one to three prior systemic treatment regimens and have folate receptor alpha (FR) positive, platinum-resistant epithelial ovarian, fallopian tube, or pr...
mirvetuximab-soravtansine-gyn

Scan the code